Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 132 | 135 | 135 | 134 | 132 |
| Accounts receivable | 3 | 2 | 31 | -17 | 44 |
| Accounts payable and accrued liabilities | 66 | -144 | 84 | -271 | 319 |
| Other Working Capital | 180 | 20 | -41 | -123 | 223 |
| Other Operating Activity | -671 | -463 | -768 | -365 | -984 |
| Operating Cash Flow | $-289 | $-450 | $-559 | $-643 | $-266 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 0 | 2 |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $2 |
| Beginning Cash Position | 897 | 1,347 | 1,905 | 2,548 | 2,812 |
| End Cash Position | 608 | 897 | 1,347 | 1,905 | 2,548 |
| Net Cash Flow | $-289 | $-450 | $-559 | $-643 | $-263 |
| Free Cash Flow | |||||
| Operating Cash Flow | -289 | -450 | -559 | -643 | -266 |
| Free Cash Flow | -289 | -450 | -559 | -643 | -266 |